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Pluripotent  hemopoietic  stem  cells  (PHSC) 1 are  operationally  defined  by  their 
ability to generate all of the cellular components of the lymphohemopoietic system 
while retaining the capacity for extensive self-replication. The existence of PHSC has 
been documented by the in vivo spleen colony-forming unit (CFU-S) assay (1) and by 
cell tracer studies (2, 3). The major obstacles to the isolation of PHSC have been their 
paucity  in  hemopoietic  tissues  (4),  their  close  physical  similarities  to  myeloid  and 
erythroid progenitor cells (5, 6), and the absence of a stem cell-specific isotypic marker 
(7). 
Myeloid progenitor cells are committed to differentiation along one or at most two 
pathways of leukocyte development. They can be identified and enumerated opera- 
tionally by their ability to produce colonies of differentiated leukocytes in semisolid 
medium in the presence of specific colony-stimulating factors (CSF) (8). Consequently 
they are referred to as in vitro colony-forming cells (CFC). To date, progenitor cells 
have been identified  for neutrophilic  granulocytes  ((3) and macrophages (M)  (GM- 
CFC), eosinophils (EO) (EO-CFC) and megakaryocytes (MEG) (MEG-CFC). Cluster- 
forming cells, which produce small aggregates of G and/or M  in vitro, are thought to 
be progeny of GM-CFC. 
Single-cell transfer experiments have demonstrated the clonal origin of G  and M 
(9).  Results of subcloning studies have suggested that progenitors of G  are ancestral 
to  progenitors of M  (10).  This  view has been  reinforced  by experiments  in  which 
developmentally discrete subsets of GM-CFC have been partially resolved by velocity 
sedimentation (11). 
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Infecuous Diseases and Contract NOI-CB-74148 from the National Cancer Institute, U  S  Public Health 
Service. The work reported in this paper was undertaken during the tenure ofan American Cancer Society- 
Eleanor Roosevelt-lnternational Cancer Fellowship awarded by the International Union Against Cancer 
to Dr Goldschnelder 
l Abbrevmtzons used m thzs paper" CFC, m v,  tro colony-forming  cell(s), CFU-S, in  vlvo spleen colony- 
forming umt, CSF, colony-stimulaung  factor(s), EBSS, Etsen's balanced salt solution; EO, eosmophd(s), 
FACS, fluorescence-actmvated  cell sorter, FCS, fetal calf serum; FITC, fluorescein isothlocyanate, G, 
neutrophdic granulocyte(s); M, macrophage(s) or monocyte(s), MEG, megakaryocyte(s),  PHSC, plunpo- 
tent hemopoletlc stem cells, PMN, polymorphonuclear leukocytes; RBC, erythrocyte(s), SCM, spleen- 
condmoned medmm, TdT  +, terminal deoxynucleoudyl transferase  positive 
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In the present study we use the fluorescence-activated cell sorter  (FACS)  (12)  to 
isolate PHSC  from rat bone marrow and to identify three subsets of GM-CFC. We 
also  describe  two  populations of  presumptive  modulator  cells  that  influence the 
seeding efficiency and differentiation of PHSC in the CFU-S assay. 
The  separation protocols derive  from  earlier observations that  Thy-1  antigen is 
present  on  many hemopoietic cells in the  rat  (13),  which  include PHSC  (14,  15), 
presumptive thymocyte progenitors (16), early members of the B  lymphocyte series 
(17-19),  and,  possibly,  progenitors  of  erythrocytes  and  myeloid  cells  (20).  These 
observations are confirmed and extended in the present study by detailed analysis on 
the  FACS of the  distribution of Thy-1  antigen among rat  bone marrow cells. The 
results  indicate  that,  in  this  species,  Thy-1  antigen  is  present  on  all  lineages  of 
lymphohemopoietic cells, and that, within each lineage, the concentration of Thy-1 
antigen is inversely related to the state of differentiation of the member cells. 
Materials and Methods 
Animals.  7- to 9-wk-old male and female DA strain rats were used as donors of bone marrow 
cells  Comparable results have been obtained with Lewis strain rats (data not shown)  In some 
experiments, donor rats were given cortisone acetate 50 mg i.m./100 g of body wt 36 h before 
harvest of the bone marrow cells. 5- to 7-wk-old syngeneic rats given 750 rad of whole body x- 
irradiation 6 h before cell transfer were used as recipients in the CFU-S assays. Irradiated rats 
were maintained on oxytetracycline, 1 0 mg/ml drinking water 
Preparation of Bone Marrow Cell Suspensions.  Bone marrow cells were collected from individual 
femoral shafts by flushing the marrow cavity with Elsen's balanced salt soluuon (EBSS). The 
dispersed cells were  filtered through a single thickness of porous lens paper to remove debris, 
and washed in two changes of cold EBSS. Cells from two or three different animals were pooled 
for  each  experiment  Viability counts  were  performed  with  0.1%  trypan  blue  In  some 
experiments, erythroeytes (RBC)  were lysed by suspending 2 ×  l0  s nucleated bone marrow 
cells in 10 mi 0.168 M NH2C1 for 7 min at room temperature  The cells were then centrifuged 
at 2,000 g for 7 min at 4°C and washed in two changes of cold EBSS. The RBC ghosts  were 
removed by layering the cells on 2 ml of fetal calf serum (FCS) and centrifuging at 2,000 g for 
7 mln 
Cell Sorting  Bone marrow cells were separated  according to relative low-angle (1.5-15  °) 
light scatter and relative fluorescence intensity for Thy-1 antigen on a FACS (FACS II, Becton, 
Dickinson & Co., Rutherford, N. J ) as described previously (14) 
Immunofluorescence.  2 ×  l0  s nucleated bone marrow cells were incubated for 20 min at 4°C 
with a  1-160 dilution (1.9 p.g/ml) of fluorescem tsothiocyanate (FITC)-F(ah')2 rabbit anu-Thy- 
1 anubodles in 0.25 ml EBSS. The cells were washed three times and diluted to 5 ×  106 cells/ 
ml in EBSS for sorting on the FACS  Control experiments with an equivalent concentration of 
FITC-F(ab')~ rabbit  anu-Thy-I serum  absorbed  with  rat  thymocytes stained <2%  of the 
nucleated bone marrow cells, none of which was PHSC or CFC  The FITC-F(ab')~ rabbit IgG 
antibody to  purified rat  brain Thy-l.1  antigen was  the  generous gift  of Dr.  R. J  Morris 
(Imperial Cancer  Research  Fund Laboratories,  London, England). The  antiserum had  an 
lmmunofluorescence  titer of 1:640 against 8 ×  l0  s rat bone marrow cells/ml. Proof of specificity 
for Thy- 1 anugen has been presented elsewhere  (14, 17) 
Cytology.  Cell smears were prepared with the aid of a  cytocentnfuge (Shandon Southern 
Instruments Inc, Sewickley,  Pa) and stained with May-Grunwald-Giemsa  stain  Differential 
cell counts were routmely performed on 1,000 cells/smear. Cell diameters were determined with 
a cahbrated ocular micrometer. Results represent the means of three to six separate experiments 
Electron Mzcroscopy.  Cells were collected from the FACS directly into fixative (2% glutaral- 
dehyde and 2% paraformaldehyde In 0 08 M cacodylate buffer)  The sample was centrifuged 
to form a pellet, the fixative was removed, and the fixed cells were resuspended in horse serum 
diluted 1 1 with water. This mixture was then placed into a cellulose nitrate centrifuge tube 
(3A6 ×  1% in ) and gently centrifuged to sediment the cells  Excess horse serum was removed I  GOLDSCHNEIDER, D  METCALF, F  BATTYE,  AND T  MANDEL  421 
and 2.5% glutaraldehyde was carefully layered on top to cross-link the horse serum surrounding 
the cells. The bottom of the tube was then cut off, and, after postfixation in 2% OsO+ followed 
by 2 h in 2% aqueous uranyl acetate, the sample was dehydrated in a graded series of acetone. 
The acetone dissolved the cap of cellulose nitrate around the cell pellet, and, after embedding 
in  Spurr's resin,  the sample was cut,  stained, and  examined  in  a  Philips EM  300  (Philips 
Electronic Instruments, Inc, Mahwah, N. J ). This collection procedure enabled 104-105 cells 
to be processed without loss for electron microscopy. 
CFU-S Assay  for PHSC (1).  1.0 X  104 to 1.0 X  106 nucleated bone marrow cells in 1.0 ml of 
EBSS plus 10% FCS were injected intravenously into irradiated (750 rad) syngeneic recipient 
rats. Spleens from recipients were harvested  12 d  later, fixed in 5% acetic acid-10% formalin- 
85% ethanol solution, and examined for macroscopically visible colonies. Paraffin-embedded 
spleen sections were stained with hematoxylin and eosin and examined for colony morphology. 
The number of cells injected was chosen to yield between  10 and 60 discrete colomes/spleen. 
Prelimmary experiments confirmed  the  linearity of the dose-response relationship noted  in 
other studies (14, 20). 
CFC Assay for GM-CFC.  Rat  bone  marrow  cells were  cultured  in  semisolid agar  (final 
concentration  of 0.3%)  with  a  modification  of the  technique  published  by  Bradley  and 
Siemtenowicz (21). 8 ×  10  a to 1 ×  105 nucleated cells were cultured for 7 d  (37°C,  10% CO2 in 
air) m  35-mm plastic Petri dishes (T. C. plates; Falcon Labware, Div  of Becton, Dickinson & 
Co, Oxnard, Calif) in a final vol of 1 ml of agar medium. 
The agar medium was an equal volume mixture of 0.6%  bacto-agar and double-strength 
Dulbecco's modified Eagle's medium,  prepared as described previously (8)  Human  ol  rat 
plasma,  heated  to  56°C  for  30  min  and  centrifuged  at  3,000  rpm  for  l0  min  to  remove 
precipitate, were added at a final concentration of 20% vol/vol. 
Colony formation was stimulated by the addition of 0.1  ml GM-CSF diluted in 5% FCS in 
normal saline. Rat spleen-conditioned medium (SCM) induced with phytohemagglutmin was 
used as the standard source of CSF for GM-CFC. The culture conditions for producing rat 
SCM were identical to those described for mouse SCM (22)  Active batches of CSF were pooled, 
aliquoted, and stored at -20°C  Results were comparable to those obtained with highly purified 
mouse GM-CSF (kindly provided by Dr. A. W. Burgess, Walter and  Eliza Hall Institute of 
Medical Research, Melbourne, Victoria, Australia). 
Enumeration of colonies (>_40 cells) and clusters (<40 cells) in semisohd agar cultures and 
cytological examination of cells in individually harvested colonies was conducted according to 
standard procedures of this laboratory (8). 
Complement-rnedzated Cytotox,czty.  2.5 X  106 nucleated rat bone marrow cells were incubated 
(30 mm at 4°C)  in 50 #l of serially twofold-diluted anti-Thy-l serum  The cells were washed 
three times tn EBSS and  incubated  (30  min at  37°C)  in 50/tl of normal guinea pig serum 
(agarose absorbed, final dtlution,  1:6) as a  complement source. The cells were washed twice 
and assayed for CFC activity. 
Three anti-Thy-I sera were tested: (a) rabbit IgG anti-rat brain Thy-1 antigen (14,  17),  (b) 
mouse antl-Thy-l.1 (Call anti-AKR thymocytes), kindly provided by Dr. I. McKenzie (Austin 
Hospital, Heidelberg, Victoria, Australia), and  (c) mouse anti-Thy-1 2  (AKR anti-Call thy- 
mocytes), kindly provided by Dr.  K. Shortman  (Walter and  Eliza Hall Institute of Medical 
Research)  Complement controls and thymocyte-absorbed antiserum controls were included in 
each expertment. 
Results 
D+strzbutzon Profiles of FA CS-separated Bone Marrow Cells 
Rat  bone  marrow  cells form  three distinct peaks  according to  relative low-angle 
light  scatter, a  function  of cell size  (Fig.  1).  Peak  I  contains  mature  RBC;  peak II 
contains mainly lymphoeytes and late erythroblasts; and peak III contains a  mixture 
of undifferentiated cells, early erythroblasts, and members of the myeloid cell series 
(Table I). Of the latter, myeloblasts and myelocytes are concentrated in the right side 
of peak III. 422  ISOLATION OF HEMOPOIETIC STEM AND PROGENITOR CELLS 
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FiG  1  Relauve size distribution of rat bone marrow cells as determined by low-angle light scatter 
Vertical threshold markers dehneate cell fractions that were separated for functional and morpho- 
logical study These fractions are designed by roman numerals to indicate the peaks from which the 
cells were obtained  L, left side of peak, R, right side of peak. The mean diameter (M) of cells (± 
SD) m each peak is indicated The mean percentage of nucleated cells in each fraction is given in 
Table III 
TArq.E  I 
Class~ficatzon of Rat Bone Marrow Cells Separated According to Relatwe Low-Angle Lzght Scatter and 
Fluorescence  for Thy-I Antzgen 
Percent of cell types* 
Classlficatton of cells  Unfractton-  Peak II*  Peak Ill* 
ated bone 
marrow:~  Total  lit.  lln  Thy- I +  Thy- I-  Total  llh.  IIIR  Thy- 1  ÷  Thy- 1  - 
%  ~  ~7~ 
Undlfferenuated cells  9 (3)  5  2  b  7  0  13  I0  13  33  0 
Lymphocytes  22 (10)  48  51  47  58  34  3  5  3  6  1 
Myelobl~ts/promyelocytes  2 (4)  0  0  0  0  0  3  1  6  5  0 
Myelocytes  6  (8)  0  0  0  I  0  7  2  12  3  I 1 
Metamyelocytc~/PMN  24 (40)  3  2  2  1  14  43  51  34  2  65 
Monocvt~  (all stag~)  5 (8)  0  0  0  1  6  9  7  11  1  13 
EO (all stages)  5 (5)  I  0  0  0  0  7  7  4  3  5 
Erythroblasts (all stages)  26 (22)  43  46  46  32  44  14  16  15  45  5 
Mttotlc figures  1 (I)  0  0  0  I  0  1  0  2  2  0 
•  bet  Ftgs  I  3 fol dc-,ertptJon of fraction,  Means of three experiments  Peak I (not shown) contained  mature RBC 
:~ Not processed on the FACb  Numb~r~ m partnthc~a.~ refer to |zercentagc ofcell types m bone marlow from cottt~ont acetate-treated  tats (r~) 
nag I m/14)0 g of body wt 3b h prcvtouslJ,) 
Fig.  2  shows  the  fluorescence-distribution profile  of DA  rat  bone  marrow  cells 
incubated with excess FITC-F(ab')2 antibodies to Thy-1 antigen. A  mean of 47.1% of 
nucleated  bone  marrow  cells were  Thy-1 ÷.  Results  in  Table I  show  that  the  great 
majority of undifferentiated cells, myeloblasts, early erythroblasts, and  mitotic cells 
are Thy-l÷;  as are  ~75%  of the bone  marrow  lymphocytes. Most of the latter cells 
have  previously  been  shown  to  be  surface  Ig  ÷  (17,  18).  The  great  majority  of 
myelocytes, mature granulocytes, monocytes, and late erythroblasts are Thy-1-. 
The relative size distribution of the Thy-1 ÷ bone marrow cells is shown  in Fig. 3 
and Table II. Approximately 64% of peak II cells and 26% of peak III cells were Thy- 
1  +, accounting for 76 and 24% of total Thy-1 ÷ bone marrow cells, respectively. 
Treatment  of donor  rats  with  cortisone  acetate  caused  a  selective  depletion  of 
lymphocytes and undifferentiated cells, and a  4.5-fold decrease in the percentage of 
Thy-1 + bone marrow cells (Tables I and II). I  GOLDSCHNEIDER,  D  METCALF,  F  BATTYE, AND T.  MANDEL  423 
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Fio.  2.  Relative fluorescence distribution of rat bone marrow cells incubated with FITC-F(ab')2 
anu-Thy-I serum. The marker defines the threshold above and below which cells were sorted into 
Thy-1 + (fluorescing) and Thy-1- (nonfluorescing) populations, respectively. In this figure, 46.6% of 
the nucleated cells was Thy-1 ÷ 
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FIG.  3  Relative  size distribution  of Thy-I +  (fluorescing)  rat  bone  marrow  cells  (broken  line) 
superimposed on  relauve size  distribution  of total  nucleated  bone  marrow  cells  (solid  line)  as 
determined by low angle-light scatter. RBC (formerly peak I) were lysed with 0.168 M  NH4CI  The 
small peak immediately to the left of peak II represents dead cells and cell debris. In this figure, 69% 
of peak II cells and 30% of peak III cells were Thy-1 + 
PHSC (CFU-S) 
SEPARATION ON THE FACS.  Approximately 89% of PHSC were distributed between 
peaks II and III of the light-scatter profile as determined by the CFU-S assay (Table 
III). Of these, 80% were in the left side of peak III. Approximately 12% of the total 
CFU-S  was present  in  the right side of peak III,  as was  97% of the GM-CFC  (see 
below). 
Results in Table IV show that CFU-S are strongly Thy-1  +. Virtually all CFU-S 
were recovered in the upper 25th percentile of cells that were separated according to 
relative fluorescence intensity for Thy-I antigen (Fig. 4); and >98% was recovered in 
the upper 10th percentile of Thy-1  + cells. 
Analysis of the relative size distribution  of cells in the upper 25th percentile for 
Thy-1 fluorescence revealed two distinct but overlapping populations (Fig. 5 A). The 
distribution of the larger cell type roughly corresponded to that of peak III cells; the 
distribution of the smaller cell type corresponded to that of cells in the valley between 
peaks II and III, which include cells that contain the enzyme terminal deoxynucleo- 
tidyl transferase (23). Pretreatment of donor rats with cortisone acetate caused a 96% 
reduction  in  the  population  of smaller  cells  (Fig.  5B),  and  resulted  in  a  twofold 
increase in CFU-S activity (Tables III and IV). 424  ISOLATION OF  HEMOPOIETIC  STEM  AND PROGENITOR  CELLS 
TABLE  II 
Dtstnbutwn of Thy-1 + Cells m Rat Bone Marrow According to Relatwe Low-Angle Ltght Scatter 
Fraction* 
Untreated bone marrow cells:t:  Cortisone-treated bone marrow 
cells:~ 
Percentage of  Percentage of  Percentage of  Percentage of 
Thy-1 + cells/  total Thy-I +  Thy-1 + cells/  total Thy-I ÷ 
fractton  cells§  fractmn  cells§ 
%  %  %  % 
I  <1  <1  <1  0 
II  64 ±  4 2  75 9 
III  26 +  4 9  24 1  7 3¶  32 3¶ 
IIIL  25 ±  3 6  11 6  ND  ND 
IIIR  25 ±  3 7  12 5  ND  ND 
Unseparatedl[  47 ±  6 6  --  10 4  -- 
* See Fig.  1 for descripuon of fractions 
~: Means  ±  SD  of four  to  six experiments (untreated  bone  marrow  cells),  mean of three  experiments 
(cortisone-treated bone marrow cells)  See Figs  2 and 3 for distribution profiles ofThy-1 + cells  ND, not 
determined 
§ Expressed as a percentage of Thy-1 + cells in unseparated bone marrow 
I[ Bone marrow ceils processed on FAGS but not separated Into fractions 
¶ Fractions IIR and IIIL combined 
TABLE  III 
Dtstrtbutzon of CFU-S tn Rat Bone Marrow According to Relatwe Low-Angle Lzght Scatter 
Fraction* 
Untreated bone marrow cells~  Cortisone-treated bone 
marrow cells:~ 
Percent-  Percent-  Number  Percent- 
Percentage of  Number of  age of  of  age of 
total nu-  CFU.S/IO 6  age of  total nu- 
total  CFU-S/  total 
cleated cells  cells  CFU-S§  cleated 
ceils  10  e cells  CFU-S§ 
%  ~  %  % 
I  <1  0  0  <1  0  0 
Ih~  30 ±  6 5  0  0  23  0  0 
IIa  24 ±  36  19± 30  175  21 
IIIL  22 ±  3 6  83 ±  16.9  71 0  25  93¶  87¶ 
IllR  24 ±  3 9  12 :t: 3.4  11 5  31  21  13 
Unfractionatedl[  --  27 ±  6 5  --  --  52  -- 
* See Fig  1 for description of fractions 
:[: Means +  SD  of four  to  six experiments (untreated  bone  marrow  cells),  mean of three experiments 
(cortisone-treated bone marrow cells)  Values for CFU-S are not adjusted for seeding efficiency 
§ 95% of GFU-S originally present in unfractionated bone marrow were recovered  m  fractions IIR, IIIL, 
and IIIR 
II Not processed on the FAGS 
¶Fracttons IIR and IIIL combined 
Hence,  the  final  protocol  for  isolating  PHSC  consisted  of selecting  the  upper  10th 
percentile  of  Thy-1 ÷  cells  in  fractions  IIR  and  IIIL  (Fig  1)  of  bone  marrow  from 
cortisone-treated  rats.  This  resulted  in a  mean  320-fold  enrichment  of CFU-S,  which 
was  78%  of  the  predicted  enrichment  (Table  IV).  In  contrast,  when  bone  marrow I  GOLDSCHNEIDER,  D  METCALF,  F  BATTYE, AND T  MANDEL  425 
TAr~CE IV 
Dzstrtbutwn of CFU-S m Rat Bone Marrow According to Relatwe Fluorescence Intenstty  for Thy-1 Antzgen 
Untreated bone marrow cells  Cortisone-treated bone marrow cells 
Thy-l + cells per-  Number of  Observed  Predicted  Number of  Observed  Predicted 
centde*  CFU-S/10  s  enrich-  enrich-  CFU-S/10  s  enrich-  enrlch- 
cells:~  ment§  mentll  cells:~  merit§  ment]l 
91-100  3,693 ±  713  151  45  7,802 ± 450  320  410 
76-100  1,542 + 260  63  18  ND  ND  164 
76-90  25 ±  5.9  1  --  29 ±  11.7  1  -- 
1-76  0.9±05  <1  --  00  <1  <1 
1-100  119±28  4.9  45  1,117±186  46  41 
0¶  00  <1  --  O0  <1  -- 
Unfractionated  24 4 ± 3.9  --  --  45 3 ±  11.4  1 9  1 6 
* Thy-1 + cells in fraction IIR +  Illr (Figs  1 and 3, Table II) were separated mto percentiles according to 
relative fluorescence intensity as dlustrated m Fig  4. 
Means ±  SD of four to six experiments. CFU-S values not adjusted for seeding efficiency 
§ Number of times greater than value for unfractionated bone marrow cells  ND, not determined 
I[ Calculated as the reciprocal of the percentage of total cells recovered in each fraction. 
¶ Thy-1- cells;  ~52% of ceils m  fraction Iln +  IIIL from untreated bone marrow and 92% of cells  from 
corusone-treated bone marrow 
U4 
Z 
uJ 
> 
n-5Olllsl- 
U/\%°" 
RELATIVE 
FLUORESCENCE INTENSITY 
Fm  4.  Relattve fluorescence distrtbuuon of rat bone marrow cells incubated with FITC-F(ab')z 
anu-Thy-I  serum  FACS  analysis of cells  in  fractions IIR  and  lilt,  (Fig.  1)  The  numbers  m 
parentheses indicate the percentiles of Thy-I + cells m the fracuons between the vertical threshold 
markers according to relative fluorescence mtenslty. In this figure, 53% of the total nucleated cells 
was Thy-1 + 
cells from untreated  rats were used, the observed enrichment  of CFU-S  (151-fold) was 
3.3 times greater than  the predicted  enrichment. 
MORPHOLOGY  OF CANmDAXE PHSC.  (a) Light mtcroscopy. Approximately  76% of the 
cells  in  the  stem  cell-rich  fraction  of bone  marrow  from  cortisone-treated  rats  was 
undifferentiated  mononuclear  ceils. These  cells had  a  broad  rim of basophilic agran- 
ular cytoplasm  surrounding  a  centrally placed  round  to oval leptochromatic  nucleus 
that contained  one or more nucleoli (Fig. 6). The  mean cell diameter  in cytocentrifuge- 
processed  smears  was  11.2  -I-  1.3  jam.  Although  there  was  some  heterogeneity  with 
respect  to  cell  and  nuclear  shape  and  degree  of cytoplasmic  basophilia,  no  discrete 
subsets were distinguished  at the light microscopic level. The  population  of undiffer- 
entiated mononuclear  cells was restricted to the upper  10th percentile of Thy-1 ÷ cells. 
Most  of the remaining  cells in the stem cell-rich fraction were polychromatophilic 426  ISOLATION OF HEMOPOIETIC  STEM  AND PROGENITOR  CELLS 
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Fm  5  Relative size dlstnbutmn  of strongly Thy-I + (upper 25th percentde)  rat bone marrow cells 
(broken  line) superimposed on relative sine distributmn  of total nucleated  bone marrow cells (solid 
hne)  as determined  by  low-angle  hght  scatter.  (A)  Bone  marrow  from  untreated  rats  (B)  Bone 
marrow from rats rejected with cortisone acetate, 50 mg/100 g body wt, 36 h before harvesting. 
erythroblasts  (mean diameter 9..5 :t:  1.2 #m).  Many showed evidence of early hemo- 
globinization  in  the  perinuclear  region  as  determined  by  a  positive  reaction  with 
dimethyloxybenzidine (24). 
(b)  Electron Microscopy. Two  subsets  of undifferentiated  mononuclear  cells  were 
distinguished  ultrastructurally  in the stem  cell-rich  fraction.  These  were  present  in 
roughly  equal  proportions.  Type  1  cells  were  generally  round  cells  with  smooth 
margins and contained a round leptochromatic nucleus that frequently had a prom- 
inent  central  nucleolus  (Fig.  7 a).  The  cytoplasm  of  these  cells  contained  many 
monoribosomes. Type 2 cells were similar in size to type  1 cells, but differed in that 
their nuclei were more irregular in outline and had more condensed chromatin and 
smaller, less obvious nucleoli (Fig.  7 b). The cell outline of type 2 cells was also more 
irregular than that of type  1 cells;  and the cytoplasm  was  more electron dense and 
contained a greater concentration of organelles. 
DISTRIBUTION OF  SPLEEN  COLONIES  IN CFU-S  ASSAY.  The  distribution  of  the  various 
colony types formed  in spleen  by CFU-S  from  unfractionated and FACS-separated 
bone marrow cell suspensions is shown in Table V. Erythroid colonies outnumbered 
granulocytic colonies by ~4:1 and other colony types by 8:1. Separation of total Thy- 
FIo  6  PHSC candidates  May-Grunwald-Glemsa stain  (a and b) Undifferentiated  mononuclear 
cells  from  310-fold  and  328-fold  enriched  suspensions  of  CFU-S  Selected  to  illustrate  typical 
features of candidate  PHSC  Note the moderate  amount  of basophihc cytoplasm,  scattered  mtra- 
cytoplasmic vacuoles,  and  lucent  permuclear  zone,  and  the  large  round  to  oval  leptochromat~c 
nucleus with one or more nucleoh (6b, insert). ×  775. 
FiG  7  Electron  micrographs  of undifferentiated  cell  types  from  a  fraction  of rat  bone  marrow 
cells enriched 310-fold for PHSC  (a)  Type  1 cells have a  generally electron-lucent  cytoplasm  that 
contains many  mononbosomes,  a  few  mitochondria,  and  occasional vacuoles. The cell  outhne ~s 
relatively smooth  and  the nucleus  is leptochromatic  and contains  a  well-developed  nucleolus. (b) 
Type 2 cells have a somewhat  more electron-dense cytoplasm and an irregular nucleus with a more 
condensed chromatm pattern.  ×  5,800 
FIo.  8.  Cell types present  m  fractions  of rat  bone  marrow cells enriched  for GM-CFC  (Thy-1 +) 
and GM-cluster-forming  cells (Thy-1-)  May-Grunwald-Giemsa  stare  See Table I  for differenual 
cell counts  (a) Thy-l* cells, fraction IIIa. Undlfferenttated monouclear cells, myeloblasts, basophdlc 
erythroblasts, large lymphocytes,  and a  mitotic cell are represented  (b)  Thy- 1- cells, fraction IIIn 
Myelocytes, PMN, monocytes, and a plasma cell are represented  ×  775 427 428  ISOLATION OF HEMOPOIETIC STEM AND PROGENITOR CELLS 
TABLe  V 
Classtficatzon of Hemopo~etzc Spleen Colomes Formed  by Rat Bone Marrow CFU-S Separated on the 
FACS* 
Colony type 
Unfraction-  Percentage of colomes formed by 
ated bone  Thy-1 ÷ cells§ 
marrow  1-100th  76-100th  91-100th 
cells~  percentile  percenule  percentile 
Untreated bone marrow 
Erythrocytlc  62  60  69  77 
Granulocytlc  15  14  14  7 
Megakaryocyuc  8  9  9  4 
M ixed  7  10  8  3 
Undifferentiated  8  7  1  9 
Cortisone-treated  marrow 
Erythrocyuc  58  60  ND  92 
Granulocytlc  18  20  ND  6 
Megakaryocyuc  5  0  ND  0 
Mixed  10  10  ND  3 
Undlfferenuated  8  10  ND  0 
* Means of three expertments  ND, not determined 
:~ Not processed on the FACS 
§ Separated from fraction IIR + IIIL according to relative fluorescence mtens,ty for Thy-I antLgen (Table 
IV) 
1  ÷ cells on  the FACS did not  alter these ratios, except  for the apparent  absence of 
megakaryocytic colonies  in  recipients of cortisone-treated  bone  marrow.  However, 
separation of the upper  25th  percentile of Thy-1 + cells, and especially of the upper 
10th percentile, increased the erythroid:granulocytic ratio to 10-15:1. Moreover, there 
appeared subjectively to be a  marked increase in the average size (cellularity) of all 
colony types and in the proportion of mature cell types present within each colony. 
GM-CFC 
EFFECT  OF  ANTI-THY-I SERUM AND  COMPLEMENT.  Treatment  of  adult  rat  bone 
marrow  cells with  anti-Thy-1  serum  and  complement  reduced the number  of GM- 
CFC  between  60  and  75%  as assayed by the CFC  assay  (Table VI). This  was  true 
whether  rabbit  heteroantiserum  to  purified  rat  brain  Thy-l.1  antigen  or  mouse 
alloantiserum to Thy-1.1 antigen was used. Neither complement alone nor antiserum 
alone  had  any  effect;  neither  did  anti-Thy-l.2  alloantiserum  plus  complement 
Absorption of the rabbit or mouse anti-Thy-l.1 serum with  rat  thymocytes or Thy- 
1.1 + (but not Thy-l.2  +) mouse thymocytes removed the cytotoxic antibodies to GM- 
CFC, further attesting to the specificity of the reaction. 
GM-cluster-forming cells were  not  affected by  treatment  with  rabbit  anti-Thy-1 
serum  plus complement,  even  when  exposed  to  an  antibody concentration  20-fold 
greater than that used against GM-CFC. 
SEPARATION OF  GMoCFC  SUBSETS  ON  THE  FACS.  GM-CFC  and cluster-forming cells 
are among  the  largest cells in  rat  bone  marrow  as judged by relative light scatter, 
Results in Table VII show that >99% of GM-CFC and >98% of GM-eluster-forming 
cells are present in the right side of peak III. In addition, all EO-CFC and MEG-CFC I  GOLDSCHNEIDER,  D.  METCALF,  F  BATTYE, AND T. MANDEL 
TABLE  VI 
Effect of Antt-Thy-I Serum on GM-CFC and Cluster-forming Cells m Rat Bone Marrow 
429 
Antiserum (Dilutmn)  Comple-  Number of colomes/  Number of clusters/ 
ment  l0  s cells*  105 cells* 
--  --  101 4- 11 3  668 +  144 
--  +  1084-  13.4  6194-  117 
Rabbit antt-Thy-l.1 (1:10):[:  -  99 4- 9.6  655 4- 76 
Rabbit anti-Thy- 1.1 (1 : 10):]:  +  26 4- 9 0  661 4- 120 
Mouse anti-Thy-l.l (1:5)§  -  98 4- 8 7  ND¶ 
Mouse anu-Thy-l.1 (1.5)§  +  42 4- 6.2  ND 
Mouse anti-Thy-l.2 (1.5)[  I  -  95 4- 11 4  ND 
Mouse anti-Thy-l.2 (I.5)H  +  102 4- I0 8  ND 
* Determined on day 7 of in vitro culture  Means 3= SD of four to six experiments. 
Rabbit IgG against rat brain Thy-I 1 antigen  Cytotoxtcity titer against rat GM-CFC,  1.80 
§ Cytotoxicity titer against rat GM-CFC,  1:10 
[I Cytotoxlcity tlter against Thy-I 2 mouse thymocytes, 1:20. 
¶ Not determined 
TABLE  VII 
D,strtbutzon of GM-CFC and Cluster-forming Cells m Rat Bone Marrow According to Relatwe Low-Angle 
Light Scatter 
Number of colonies/  Enrich-  Number of clusters/  Enrich- 
Fraction*  I0  s cells:[:  ment§  10  s cells:~  ment§ 
I  00  <1  00  <1 
IIL  0.0  < 1  0.0  < 1 
IIR  0.2 +  04  <I  0.2 +  0.5  <1 
IIIL  3 9 +  5.4  <1  15.0 +  23.3  <1 
Ilia  587 5 +  150.0  4 7  813 2 +  166 5  1 3 
Unfractmnated  u  125 4 4- 23 3  --  612.2  4- 124 8  -- 
* See Fig  1 
Determined on day 7 of in vltru culture. Means :1: SD of four to eight experiments 
§ Number of umes greater than value m unfractionated bone marrow cells  All GM-CFC and 32% of GM- 
cluster-forming cells were recovered after separation on the FACS. 
1[ Not processed on the FACS. 
that  were  identified  were  restricted  to  this  fraction,  although  a  systematic  study  of 
these cell types using optimized  culture conditions was not undertaken. 
Results in Table  VIII show that >95%  of GM-CFC  are Thy-I +  and  that >85%  of 
GM-cluster-forming  cells are Thy-1-.  Both figures are probably  conservative inasmuch 
as  there was  a  moderate  degree  of overlap  between  Thy-1 ÷  and  Thy-1-  cells in  the 
fluorescence profile. 
Isolation of the Thy-1 +  cells in fraction  IIIR resulted  in a  12.7-fold  enrichment  of 
GM-CFC,  close to the predicted  16-fold enrichment.  No significant further enrichment 
was  obtained  by  separating  the  Thy-1 ÷  cells  according  to  relative  fluorescence 
intensity.  However,  there was a  marked  shift in the proportions  of colony types  that 
formed  m  vitro. 
Results  in Table  IX  show  that  67%  of GM-CFC  in  the upper  25th percentile  for 
Thy-I  fluorescence  formed  G  colonies,  whereas  71%  of GM-CFC  in  the  lower  75th 
percentile  formed  M  colonies.  Progenitor  cells  that  produce  mixed  colonies,  which 430  ISOLATION OF HEMOPOIETIC  STEM AND PROGENITOR  CELLS 
T^aLE  VIII 
D,strzbutzon of GM-CFC and Cluster-forming Cells m Rat Bone Marrow According to Relat,ve 
Fluorescence Intenszty  for Thy-I Antzgen 
Number of clusters/  Thy-1 + cells in frac-  Number of colonies/  Enrichment§  Enrichment§ 
tion Ilia percentile*  105 cells.t.  10  5 cell~ 
91-100  1,224 4- 100  9.8  0.0  <1 
76-90  1,632 4- 183  13 0  0 0  •1 
51-76  1,509 ±  248  12 0  0.0  <1 
1-50  1,104 ±  194  8 8  361 ±  60  <1 
76-100  1,788 ±  349  14 3  0.0  <1 
1-75  1,240 ±  140  9.9  179 4- 25  <1 
1-100  1,588 ±  366  12.7  221 +  21  <1 
011  50 +  5 6  <1  1,289 4- 327  2 1 
* Thy-1 + cells m fraction Ilia (Table VII) were separated into percentiles according to relative fluorescence 
intensity Approximately 25% of cells in fraction IIIa were Thy-1 + 
:[: Day 7 m vitro culture  Means 4- SD of four experiments 
§ Number of times greater than value m unfractionated bone marrow cells 
II Thy-1- cells 
TABLE IX 
D~stnbutzon of GM-CFC Subsets According to Relatwe Fluorescence Intenszty for Thy-I Antzgen 
Thy-1 + cells m fraction 
IlIR percentile* 
Percent in vitro colomes:~ 
G  M  Mixed  Others 
% 
91-100  73.6  10 4  8.5  7 5 
76-90  67 8  12 4  10 7  9 1 
51-75  5 1  50 2  28 1  16 6 
1-50  29  779  124  68 
76-100  66.7 (90)11  13 1 (8)  12.0 (23)  8 2 (38) 
1-75  3 7 (10)  71 2 (92)  18.8 (77)  6 3 (62) 
1-100  23 2  48 2  18 9  9 7 
Unfractionated§  20 5  62.0  11 4  6 1 
* Table VIII, footnote. 
:~ From day 7 cultures. Mixed colonies contain both G and M, the minority population representing >10% 
of total cells in the colony. 
§ Not processed on the FACS 
II Numbers in parentheses indicate the percentage of total colonies of each type that is formed by CFC m 
the indicated fraction. 
contain both G  and  M, were found  in all fractions, but  the highest percentage  (28%) 
was present in the 51-75th  percentile of Thy-I ÷ cells. 
When  the  distribution  of  these  various  subsets  of  GM-CFC  is  expressed  as  a 
percentage  of total progenitor  cells of each  type,  the following results are obtained: 
90% of the G-CFC  were present in the upper  25th percentile of Thy-1 +  cells; 92% of 
the  M-CFC  were  present  in  the  lower  75th  percentile;  and  45%  of the  mixed  GM- 
CFC  were in the 51-75th  percentile. 
Mixing  experiments  in which  cells from the upper  25th and  lower  75th percentile I.  GOLDSCHNEIDER,  D.  METCALF,  F. BATTYE, AND T.  MANDEL  431 
of Thy-1  ÷ cells were combined at ratios of 1:3,  1:1, and 3:1 showed strictly additive 
results in terms of the per centages of G, M, and mixed GM colonies that developed. 
MORPHOLOGY OF THY-I + AND THY-I- CELLS IN FRACTION IIIR.  More than 90% of cells 
in  the  upper  25th  percentile of Thy-1  + cells in  fraction IIIR were undifferentiated 
mononuclear cells and basophilic erythroblasts; most of the cells in the lower 75th 
percentile were immature myeloid cells, predominantly myeloblasts and promyelo- 
cytes, and basophilic erythroblasts. The undifferentiated mononuclear cells in fraction 
IIIR were larger (mean diameter 12.6 +  2.0 #m) than the candidate PHSC in fraction 
IIIL and  had  eccentrically placed,  indented nuclei, and  more abundant  basophilic 
cytoplasm (Fig. 8a). 
The great majority ofThy-l- cells in fraction IIIR were myelocytes, metamyelocytes, 
and mature G and M  (Fig. 8 b). 
Discussion 
The  results  of this  study  permit  the  following  conclusions  regarding  normal 
hemopoiesis in the rat:  (a)  PHSC, GM-CFC, and GM-cluster-forming cells exist as 
discrete cell populations in bone marrow: (b) the heterogeneity of in vitro GM colonies 
reflects a corresponding heterogeneity of GM-CFC; and (c) the concentration of Thy- 
1 antigen on hemopoietic precursor cells is inversely related to their relative state of 
maturity. 
These conclusions seem justified in  view of the  virtually complete separation of 
these cell populations on the FACS  according to relative light-scatter and  relative 
fluorescence intensity for Thy-1 antigen. Fractions that contain 89% of total CFU-S 
can be separated from fractions that contain 97% of total GM-CFC solely on the basis 
of relative light scatter. Given that CFU-S and GM-CFC as routinely assayed exist in 
approximately equal  proportions in  bone marrow  (-0.2% of nucleated cells),  it  is 
apparent  that  this  degree of functional  dissociation  must  be  accounted  for by  a 
comparable degree of cellular dissociation. GM-clusteroforming cells, being Thy-1-, 
can  be  separated  from  CFU-S  and  GM-CFC,  all  of which  are  Thy-1  +.  These 
relationships are summarized in Fig. 9. 
Other attempts to separate these heretofore operationally defined cell populations 
have been only partially successful. In mouse bone marrow, CFU-S were found to be 
slightly smaller, more dense, and less adherent on average than GM-CFC (5, 25); and 
GM-cluster-forming cells were slightly larger,  less  dense,  and  more adherent  than 
GM-CFC (11). This stickiness of GM-cluster-forming cells may explain their selective 
loss on the FACS in the present experiments (Table VII). Pretreatment of donor mice 
with  Freund's  adjuvant,  irradiation,  or  vinblastine  pe.rmitted  a  greater  degree of 
separation of CFU-S and GM-CFC, but even the best experiments showed significant 
overlapping (9, 26). Marked enrichment of GM-CFC has been achieved with monkey 
and human bone marrow (27, 28), but assays for CFU°S do not exist in these species. 
Similarly marked enrichment of a subset of CFU-S from the endosteal surface of rat 
bone marrow has been achieved (29), but GM-CFC activity was not determined. 
In the present study, the observed enrichment of  CFU-S approximated the predicted 
enrichment when bone marrow cells from cortisone-treated rats were separated on the 
FACS according to relative intensity of Thy-1 fluorescence. This did not occur when 
untreated bone marrow cells were used.  Rather, the observed enrichment exceeded 
the predicted enrichment by 3.3-fold; and the percentage of morphologically identi- 432  ISOLATION OF HEMOPOIETIC STEM AND PROGENITOR CELLS 
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Fio.  9  Gated analysis of rat bone marrow cell subsets according to relauve low-angle hght scatter 
(size) and relative fluorescence intensity for Thy-I antigen on the FACS. Composite diagram based 
on data from elsewhere (23) (TdT  + cells) and this paper  "Fractions"  (abscissa) refers to gated 
fracuons separated according to relative light scatter (Fig. l)  "Pereentlle" (ordmate) refers only to 
gated fractions of Thy-1  + (fluorescing) cells (Fig 4)  All Thy-1- cells are given a value of 0, even 
though they may exhibit small amounts of nonspeclfic (background) fluorescence  by FACS analysis 
See text for description of the various designated cell subsets Lymphs, lymphocytes 
fiable  PHSC candidates  (14%)  correlated  with  the predicted  enrichment  of CFU-S 
(45-fold)  rather  than  with  the  observed  enrichment  (151-fold).  The  cause  of this 
discrepancy is  not  known,  but  several  intriguing  possibilities  exist.  Table  IV shows 
that the deviation  from the expected enrichment  occurred when the cells in the  76- 
100th percentile  for Thy-1  fluorescence were separated  from the cells in the  1-75th 
percentile. This suggests that a population of cells in the lower 75th percentile of Thy- 
1  + cells normally acts to decrease the seeding efficiency (or proliferative capacity) of 
CFU-S to spleen. 
Assuming that this hypothesis is correct, why did the same phenomenon not occur 
with cortisone-treated bone marrow cells? One highly speculative explanation is that 
there are two sets of accessory cells that  normally regulate  the seeding efficiency of 
CFU-S. The first of these is the weakly Thy-1 + suppressor cell population mentioned 
above;  the second  is  a  population  of strongly Thy-1 +, cortisone-sensitive,  amplifier 
cells. 
Another phenomenon that requires explanation  is the increased erythroid:myeloid 
spleen colony ratio caused by CFU-S from rat bone marrow depleted of weakly Thy- 
1  + cells. This phenomenon occurred with bone marrow from cortisone-treated as well 
as untreated  rats,  which suggests that  a  population  of cortisone-resistant  modulator 
cells  was  involved.  It  is  possible  that  these  modulator  cells,  being  weakly  Thy-1 +, 
belong to the aforementioned population of suppressor cells. 
The above predictions need to be tested experimentally.  However, there is evidence 
for the presence of a  Thy-1 + amplifier cell in mouse bone marrow (30, 31). This cell 
type is required to maximize the development of hemopoietic colonies in the spleens 
of recipients. It can be replaced by viable thymoeytes or by thymosin (32). Moreover, 
preliminary  evidence suggests  that  this  amplifier  cell  may, itself,  be regulated  by a I  GOLDSCHNEIDER, D  METCALF, F  BATTYE, AND T. MANDEL  433 
Thy-I  +  suppressor  cell  in  normal  mouse  bone  marrow.  As  in  the  present  study, 
removal of the putative suppressor cell increased the number of spleen colonies -2.5- 
fold; removal of both the suppressor and amplifier cells did not significantly alter the 
number of spleen colonies that developed. Also, as in the present study, perturbations 
of presumptive modulator cells altered the ratio of erythroid:myeloid spleen colonies. 
Numerous  morphological candidates  have been  proposed  for the  PHSC  (33-35). 
Most have fallen within the "lymphocyte-transitional" cell category defined by Yoffey 
(36).  Unfortunately, the degree of stem cell enrichment  in  these earlier studies was 
insufficient  to permit  a  direct  correlation  between  PHSC  activity and  a  particular 
morphological cell type. Moreover, techniques that were commonly used to enrich for 
PHSC also enrich for myeloid, erythroid, and lymphoid progenitor cells (5, 6, 37-40) 
This may account  for the  fact  that  the  number of lymphocyte-transitional cells  in 
bone marrow greatly exceeds that of PHSC. 
Recently, van Bekkum et al. (6) have proposed that a population of undifferentiated 
mononuclear  cells present  in  density  gradient-enriched  fractions of mouse and  rat 
bone marrow is the PHSC candidate. This cell type is similar ultrastructurally to the 
type  1 PHSC candidate that we have isolated on the FACS. The ratio of candidate 
PHSC  (identified morphologically):CFU°S (identified  functionally)  was consistently 
1:2  in  van Bekkum's studies  (6), which suggests that  many CFU-S do not  resemble 
type 1 cells. Several authors have demonstrated  that cycling and noncycling subsets 
of mouse  CFU-S  can  be  distinguished  by  differences  in  sedimentation  rates  and 
buoyant  densities  (Visser  et  al.  [41]).  Presumably,  cycling  and  noncycling  CFU-S 
would  differ morphologically. Ross et al.  (42)  have described  two candidate  PHSC 
from the blood of dogs. These two PHSC candidates strongly resemble the type 1 and 
type 2 PHSC candidates  from rat bone marrow. It is of interest,  therefore, that  the 
combined  percentage of type  1 and  type  2  cells  (mean  76%)  in  the  stem  cell-rich 
fraction from rat bone marrow closely approximates the predicted percentage of CFU- 
S  (mean  78%)  in  this  fraction.  The  latter  figure  is  based  on  an  assumed  seeding 
efficiency of 0.01  for rat  bone marrow CFU-S  (4),  and  is  derived  according to the 
formula:  number of spleen colonies/10  n bone marrow cells ×  enrichment  of CFU-S 
×  100 +  seeding efficiency ×  106. 
The identity of GM-CFG in rodents is uncertain.  In the mouse, cells that generate 
M  colonies in vitro tend to be larger than cells that form mixed colonies, and these, 
in turn, tend to be larger than cells that form granulocytic colonies (11). Moreover, in 
single cell transfer studies in vitro (3,  10),  cells from early granulocytic colonies can 
form colonies of M; and cells from more mature colonies can form GM-clusters. We 
have separated these progenitor cell subsets from rat bone marrow. As anticipated, G- 
CFC were associated with undifferentiated  mononuclear cells,  M-CFC with  myelo- 
blasts, and GM-cluster-forming cells with myelocytes. 
Our findings, therefore, are consistent with the view that progenitors of G  are the 
least-mature members of the GM-cell lineage, and that these bear a precursor-product 
relationship to progenitors of M  and to cluster-forming cells. As in other studies (11), 
the  results  of mixing  experiments  were  strictly  additive,  which  indicates  that  the 
patterns of colony formation observed after cell separation is a  result of the existence 
of subpopulations of GM-CFC rather than to the activities of modulator cells or to a 
stochastic  process.  The  asynchrony  of colony  development,  as  illustrated  by  the 
presence  of  three  colony  types  on  day  7  of  culture,  is  further  evidence  of  the 434  ISOLATION OF HEMOPOIETIC  STEM  AND PROGENITOR  CELLS 
heterogeneity of GM-CFC;  less-mature GM-CFC taking longer than more-mature 
GM-CFC to generate macrophages. Data presented elsewhere (43) suggest that the 
rate of this transition is,  in  part,  determined by the concentration of CSF  in  the 
cultures; high concentrations favoring the prolonged production of G, low concentra- 
tions favoring the early production of M. 
It is not possible at this time to explain the physiological significance of the inverse 
relationship that we have observed between relative fluorescence intensity for Thy-1 
antigen and relative maturity of members of the GM-cell series in rat bone marrow. 
There is no known function for Thy-1 antigen, and its distribution among lympho- 
hemopoietic cell populations varies widely between species (13-19, 44, 45). However, 
it is clear that both the absolute amount of Thy-1 antigen (as determined by relative 
fluorescence intensity in the presence of excess FITC-anti-Thy-1 antibodies) and the 
concentration of Thy-1 antigen are greater on immature than on mature hemopoietic 
cells. Thus, in the rat as in the mouse, the progressive maturation of myeloid cells 
from the level of the PHSC is characterized by a progressive increase in cell size; yet 
the relative amount of Thy-1 antigen decreases as maturation progresses. In morpho- 
logical terms, the relative concentration of Thy-1 antigen can be depicted as follows: 
undifferentiated cells  (ll.2-/~m  mean  diameter)  >  undifferentiated cells  (12.6-#m 
mean diameter) >  myeloblasts >  myelocytes >  polymorphonuclear leukocytes/mon- 
ocytes. In developmental terms, the relative coneention of Thy-1 is: CFU-S >  G-CFC 
>  mixed GM-CFC >  M-CFC >  GM-cluster-forming cells >  mature polymorphonu- 
clear leukocytes (PMN)/monocytes. These relationships are schematically illustrated 
in Fig. 9. 
Results of ongoing studies indicate that an inverse relationship also exists between 
Thy-1 concentration and maturation of other myeloid cells, RBC, and lymphocytes 
in the rat. In the EO series, the relative concentration of Thy-1 antigen is: CFU-S > 
EO-CFC >  myeloblasts/myelocytes >  EO. Similarly, early erythroblasts are Thy-I +, 
and  late erythroblasts and  mature  RBC  are  Thy-1-.  In  the T  lymphocyte series, 
putative  thymocyte  progenitors  (terminal  deoxynucleotidyl  transferase-positive 
[TdT  +] bone marrow cells)  (23) and cortical thymocytes are strongly Thy-1 +, whereas 
medullary thymocytes are weakly Thy-1 +, and a large majority of peripheral T  cells 
are Thy-1- (46). Thy-1 antigen is also restricted to the least-mature members of the 
B lymphocyte series,  being present on complement receptor-negative B cells in fetal 
liver, bone marrow, and peripheral lymphoid tissues, but not on memory B cells or 
antibody-forming cells (19). It is likely, therefore, that Thy-1 antigen will prove to be 
a useful marker with which to identify and isolate precursor cell subsets belonging to 
most of the lymphohemopoietic cell lineages in the rat. Moreover, our recent obser- 
vations suggest that antisera to nonallelic determinants on the Thy-1 molecule may 
prove useful for the isolation of lymphohemopoietic precursor cells in the mouse (47). 
Summary 
A scheme is presented whereby pluripotent hemopoietic stem cells (PHSC)  from 
rat bone marrow can be enriched 320-fold with the aid of the fluorescence-activated 
cell sorter. This scheme is based on the observations that PHSC are strongly positive 
for  Thy-1  antigen  (upper  10th  percentile);  have  light-scattering  properties  (size 
distribution)  between those of bone  marrow  lymphocytes and  myeloid progenitor 
cells; and are relatively resistant to cortisone. It is estimated that PHSC may constitute I  GOLDSCHNEIDER,  D  METCALF, F. BATTYE, AND T. MANDEL  435 
80% of the cells isolated according to these parameters. Candidate PHSC are described 
at the light and electron microscopic levels. 
At least two populations of accessory cells appear to influence the number and/or 
the nature of the hemopoietic colonies that form in the in vivo spleen colony-forming 
unit  assay.  Putative  amplifier  cells  are  strongly  Thy-I  +  and  cortisone  sensitive; 
putative suppressor cells are weakly Thy-1  ÷ and cortisone resistant. 
Three subsets of granulocyte (13) -macrophage (M) progenitor cells (in vitro colony- 
forming cells [CFC]) are identified on the basis of relative fluorescence intensity for 
Thy-1  antigen:  G-CFC are strongly Thy-l+; M-CFC are weakly Thy-l+; and  cells 
that produce mixed G  and M  CFC have intermediate levels  of Thy-1. GM-cluster- 
forming cells  and mature G  and M  are Thy-1-. The results suggest that G-CFC are 
bipotential cells that give rise to G and M-CFC; and that the latter produce mature 
M  through a cluster-forming cell intermediate. 
Thy-1 antigen is also demonstrated on members of the eosinophil, megakaryocyte, 
erythrocyte, and  lymphocyte cell  series  in  rat  bone marrow.  In each  instance,  the 
relative concentration of Thy-1  antigen  is  inversely related  to the  state  of cellular 
differentiation. 
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also  grateful  to  Dr.  Roger Morris  for his  generous  gift  of the  FITC-F(ab')I anti-Thy-1  1 
antibodies. 
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